PDPing Duan

Ping Duan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ping Duan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Chenchen Mao

    Department of General Surgery First Affiliated Hospital Wenzhou Medical University Wenzhou Zhejiang 325000 China

    1 shared publication
  • Gangqiang Guo

    Department of Microbiology and Immunology Institute of Molecular Virology and Immunology Institute of Tropical Medicine Wenzhou Medical University Wenzhou Zhejiang 325000 China

    1 shared publication
  • Jianfeng Xu

    Department of General Surgery First Affiliated Hospital Wenzhou Medical University Wenzhou Zhejiang 325000 China

    1 shared publication
  • Jun Chen

    Department of Microbiology and Immunology Institute of Molecular Virology and Immunology Institute of Tropical Medicine Wenzhou Medical University Wenzhou Zhejiang 325000 China

    1 shared publication
  • Ledan Wang

    Department of Obstetrics and Gynecology Second Affiliated Hospital Wenzhou Medical University Wenzhou Zhejiang 325000 China

    1 shared publication
  • Ruanmin Zou

    Department of Obstetrics and Gynecology First Affiliated Hospital Wenzhou Medical University Wenzhou Zhejiang 325000 China

    1 shared publication

Latest Publications

  • Open Access

    Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration

    by Yingying Hu, Xiangwei Sun, Chenchen Mao, Gangqiang Guo, Sisi Ye, Jianfeng Xu, Ruanmin Zou, Jun Chen, Ledan Wang, Ping Duan, et al.

    Long noncoding RNA s (lnc RNA s), a novel class of transcripts that have critical roles in carcinogenesis and progression, have emerged as important gene expression modulators. Recent evidence indicates that lnc RNA taurine‐upregulated gene 1 ( TUG 1) functions as an oncogene in numerous types of human cancers. However, its function in the development of cervical cancer remains unknown. The aim of this research was to investigate the clinical significance and biological functions of TUG 1 in cervical cancer. TUG 1 was found to be significantly upregulated in cervical cancer tissues and four cervical cancer cell lines by quantitative real‐time polymerase chain reaction ( qRT ‐ PCR ). Elevated TUG 1 expression was correlated with larger tumor size, advanced international federation of gynecology and obstetrics ( FIGO ) stage, poor differentiation, and lymph node metastasis. Furthermore, knockdown of TUG 1 suppressed cell proliferation with activation of apoptosis, in part by regulating the expression of Bcl‐2 and caspase‐3. Silencing of TUG 1 inhibited cell migration and invasion via the progression of epithelial–mesenchymal transition ( EMT ). Taken together, our findings indicate that TUG 1 acts as an oncogene in cervical cancer and may represent a novel therapeutic target.